Aveo Pharmaceuticals (AVEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 71,647 | 45,290 | N/A | N/A | N/A |
| Marketable Securities | 24,485 | 6,011 | N/A | N/A | N/A |
| Receivables | 5,149 | 487 | N/A | N/A | N/A |
| TOTAL | $108,813 | $53,094 | $N/A | $N/A | $N/A |
| Non-Current Assets | |||||
| PPE Net | 4,022 | 4,197 | N/A | N/A | N/A |
| Other Non-Current Assets | 1,003 | 2,553 | 0 | 0 | 0 |
| TOTAL | $5,025 | $6,750 | $N/A | $N/A | $N/A |
| Total Assets | $113,838 | $59,844 | $N/A | $N/A | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 7,302 | 7,491 | 0 | 0 | 0 |
| Accrued Expenses | 5,625 | 7,389 | N/A | N/A | N/A |
| TOTAL | $34,181 | $34,305 | $N/A | $N/A | $N/A |
| Non-Current Liabilities | |||||
| Long Term Debt | 10,275 | 12,278 | N/A | N/A | N/A |
| Deferred Revenues | 13,621 | 11,958 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 1,253 | 159,413 | 0 | 0 | 0 |
| TOTAL | $33,316 | $195,830 | $N/A | $N/A | $N/A |
| Total Liabilities | $67,497 | $230,135 | $N/A | $N/A | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,990 | N/A | N/A | N/A | N/A |
| Common Shares | 30 | 2 | N/A | N/A | N/A |
| Retained earnings | -192,103 | -177,725 | N/A | N/A | N/A |
| Other shareholders' equity | 19 | 0 | 0 | 0 | 0 |
| TOTAL | $46,341 | $-170,291 | $N/A | $N/A | $N/A |
| Total Liabilities And Equity | $113,838 | $59,844 | $0 | $0 | $0 |